Our data also indicated that SLC35B4 may be involved in pathogenesis of both schizophrenia and glioma, which provide hints that researchers may shed light on this glycosyltransferase gene for drug development of both two diseases. The gene discussed is SLC35B4; the disease is central nervous system cancer.